News

A new study shows that the health of U.S. children has deteriorated over the past 17 years, with kids today more likely to ...
Brain differences in children and teens who experiment with drugs early show up before they take their first puff or sip ...
But now is not the time to retreat into our homes to "protect" our children, pediatrician Dr. Christopher Forrest told ...
After facing an unexpected regulatory delay last month, KalVista Pharmaceuticals has leapt into the commercial realm with the ...
The FDA has approved Gamifant for the treatment of adult and pediatric patients with HLH/MAS in known or suspected Still disease.
KalVista Pharmaceuticals said on Monday the U.S. Food and Drug Administration has approved its drug for a type of hereditary swelling disorder, sending its shares up 33.3% in premarket trading.
Kids younger than 6 years on extended-release stimulants for ADHD may experience higher rates of side effects due to higher plasma exposures.
When a child refuses to settle down night after night, parents will do anything if it helps them to sleep at last. Enter melatonin gummies for kids, a product increasingly appearing on supermarket ...
Sunscreen is not one size fits all, and Maryland dermatologist Dr. Kate Viola has recommendations that fit all age groups ...
The Food and Drug Administration is revising the labeling of all extended-release stimulants used to treat attention-deficit hyperactivity disorder to include warnings about the risk of weight loss ...
A South Florida drug maker recalled 199,584 bottles of three ophthalmic solutions because of a “lack of assurance on sterility.” ...
Belimumab is now the first and only subcutaneous biologic therapy approved for at-home administration in pediatric lupus nephritis.